Neurocrine Biosciences (NASDAQ:NBIX) executives used a conference discussion to frame 2026 as a year of execution ahead of what they described as a “data-rich” 2027 across multiple mid- and late-stage ...

In the landscape of independent Canadian cinema, selling your film to A24 is the equivalent of a lightning strike. For a first-time feature director, it’s even more rare. But Canadian filmmaker Ian ...